As of 28 Aug 2026, Q-Line Biotech Ltd share price is ₹528.30. The stock opened at ₹528.30 and had closed at ₹536.95 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹431.00 and a high of ₹600.00. In terms of performance, Q-Line Biotech Ltd share price has decreased by 4.36% over the past six months and has increased by 11.31% over the last year.
QLINE Charts
Q-Line Biotech Ltd Overview
About QLINE
Q-Line Biotech are engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs.
Q-Line Biotech Ltd Historical Performance
Q-Line Biotech Ltd Fundamental Analysis
Q-Line Biotech Ltd Financials
| Indicator | No Data Available |
|---|---|
| Revenue | |
| EBITDA | |
| Net Profit | |
| EPS |
Q-Line Biotech Ltd Technical Analysis
| Indicator | Value |
|---|---|
| RSI | 52.09 |
| MACD | 3.35 |
| 20-Day SMA | 534.87 |
Q-Line Biotech Ltd Corporate Actions
| Corporate Action | Ex Date | Record Date |
|---|---|---|
| No forthcoming board meetings available. | ||
Q-Line Biotech Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Adani Enterprises LtdADANIENT | ₹3,169.00+1.83% | ₹2,39,561.75 | 16.95 | 3.93% |
| Premier Energies LtdPREMIERENE | ₹1,000.00-0.50% | ₹31,983.67 | 24.04 | 35.05% |
| Aegis Logistics LtdAEGISLOG | ₹1,298.00-2.53% | ₹22,721.99 | 23.43 | 14.83% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Q-Line Biotech Ltd today is ₹528.30 on NSE and ₹528.30 on BSE.
- The 52-week high of Q-Line Biotech Ltd is ₹600.00, while the 52-week low is ₹431.00.
- The current market capitalisation of Q-Line Biotech Ltd is approximately ₹1,232 crore.
- The P/E (Price-to-Earnings) ratio of Q-Line Biotech Ltd is 0.00. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Q-Line Biotech Ltd is 5.04. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To invest in Q-Line Biotech Ltd shares,
• Open a Demat and trading account with a registered broker
• Add funds to your account
• Search for Q-Line Biotech Ltd on the trading platform
• Place a buy order
• Track your investments - Over the past 3 years, Q-Line Biotech Ltd has delivered a return of approximately N/A. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Q-Line Biotech Ltd comprises different categories of shareholders. As of May 2026, the shareholding is approximately 67.51% promoters, 0.08% FIIs, 10.14% DIIs, and 15.97% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
